CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Activity

37 hedge funds and large institutions have $28.3M invested in Cellectar Biosciences in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 13 closing their positions.

Holders
37
Holders Change
-8
Holders Change %
-17.78%
% of All Funds
0.54%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
5
Increased
17
Reduced
8
Closed
13
Calls
$8K
Puts
$151K
Net Calls
-$143K
Net Calls Change
+$263K

Top Buyers

1
RA
1
Rosalind Advisors
Ontario, Canada
$6.76M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.91M
3
ACM
3
AIGH Capital Management
Maryland
$6.86M
4
BlackRock
4
BlackRock
New York
$572K
5
Morgan Stanley
5
Morgan Stanley
New York
$209K

Top Sellers

1
LIP
1
Lighthouse Investment Partners
Florida
$0
2
Barclays
2
Barclays
United Kingdom
$430K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
ACP
4
Acuta Capital Partners
California
$176K
5
NA
5
NewEdge Advisors
Louisiana
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
51
Concourse Financial Group Securities
Alabama
– – – –
1 2
3